<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cancer Inform</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Inform</journal-id>
<journal-id journal-id-type="publisher-id">CIX</journal-id>
<journal-id journal-id-type="hwp">spcix</journal-id>
<journal-title-group>
<journal-title>Cancer Informatics</journal-title>
</journal-title-group>
<issn pub-type="epub">1176-9351</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31488946</article-id>
<article-id pub-id-type="pmc">6710679</article-id>
<article-id pub-id-type="doi">10.1177/1176935119871933</article-id>
<article-id pub-id-type="publisher-id">10.1177_1176935119871933</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Short Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Multiple Omics Data Integration to Identify Long Noncoding RNA Responsible for Breast Cancer–Related Mortality</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-8022-6760</contrib-id>
<name>
<surname>Roy Sarkar</surname>
<given-names>Tapasree</given-names>
</name>
<xref ref-type="aff" rid="aff1-1176935119871933">1</xref>
<xref ref-type="aff" rid="aff2-1176935119871933">2</xref>
<xref ref-type="corresp" rid="corresp1-1176935119871933"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maity</surname>
<given-names>Arnab Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff3-1176935119871933">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niu</surname>
<given-names>Yabo</given-names>
</name>
<xref ref-type="aff" rid="aff2-1176935119871933">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mallick</surname>
<given-names>Bani K</given-names>
</name>
<xref ref-type="aff" rid="aff2-1176935119871933">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1176935119871933"><label>1</label>Department of Biology, Texas A&amp;M University, College Station, TX, USA</aff>
<aff id="aff2-1176935119871933"><label>2</label>Department of Statistics, Texas A&amp;M University, College Station, TX, USA</aff>
<aff id="aff3-1176935119871933"><label>3</label>Early Clinical Development Oncology Statistics, Pfizer Inc, San Diego, CA, USA</aff>
<author-notes>
<corresp id="corresp1-1176935119871933">Tapasree Roy Sarkar, Department of Biology, Texas A&amp;M University, College Station, TX 77843, USA. Email: <email>tsarkar@bio.tamu.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>18</volume>
<elocation-id>1176935119871933</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>7</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Long non-coding RNAs (lncRNAs) are a large and diverse class of transcribed RNAs, which have been shown to play a significant role in developing cancer. In this study, we apply integrative modeling framework to integrate the DNA copy number variation (CNV), lncRNA expression, and downstream target protein expression to predict patient survival in breast cancer. We develop a 3-stage model combining a mechanical model (lncRNA regressed on CNV and target proteins regressed on lncRNA) and a clinical model (survival regressed on estimated effects from the mechanical models). Using lncRNAs (such as <italic>HOTAIR</italic> and <italic>MALAT1</italic>) along with their CNV, target protein expressions, and survival outcomes from The Cancer Genome Atlas (TCGA) database, we show that predicted mean square error and integrated Brier score (IBS) are both lower for the proposed 3-step integrated model than that of 2-step model. Therefore, the integrative model has better predictive ability than the 2-step model not considering target protein information.</p>
</abstract>
<kwd-group>
<kwd>Long noncoding RNA</kwd>
<kwd>breast cancer</kwd>
<kwd>integrative modeling</kwd>
<kwd>survival model</kwd>
<kwd>TCGA</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-1176935119871933" sec-type="intro">
<title>Introduction</title>
<p>Several evidences highlight the emerging impact of long noncoding RNAs (lncRNAs) in cancer progression.<sup><xref ref-type="bibr" rid="bibr1-1176935119871933">1</xref><xref ref-type="bibr" rid="bibr2-1176935119871933"></xref><xref ref-type="bibr" rid="bibr3-1176935119871933"></xref>-<xref ref-type="bibr" rid="bibr4-1176935119871933">4</xref></sup> The aim of this study is to identify the predictive capability of some oncogenic lncRNAs in tumor progression and prognosis of breast cancer.</p>
<p>Breast cancer is the most common malignancy and the leading cause of cancer death in women. By focusing on a single type of genetic alteration such as copy number variation (CNV), scientists have identified significant genes that may contribute to cancer progression.<sup><xref ref-type="bibr" rid="bibr5-1176935119871933">5</xref><xref ref-type="bibr" rid="bibr6-1176935119871933"></xref><xref ref-type="bibr" rid="bibr7-1176935119871933"></xref>-<xref ref-type="bibr" rid="bibr8-1176935119871933">8</xref></sup> Due to its complexity, the study of cancer should focus on incorporating data from multiple platforms ranging from genes, transcripts, and proteins found in cancer cells,<sup><xref ref-type="bibr" rid="bibr9-1176935119871933">9</xref></sup> to whole biological systems, represented by molecular pathways and cell populations.<sup><xref ref-type="bibr" rid="bibr10-1176935119871933">10</xref></sup> The integration, where multiple levels of omics data (ie, CNV, methylation, and gene expression) are gathered from the same subjects and analyzed, is known as vertical integration.<sup><xref ref-type="bibr" rid="bibr10-1176935119871933">10</xref><xref ref-type="bibr" rid="bibr11-1176935119871933"></xref>-<xref ref-type="bibr" rid="bibr12-1176935119871933">12</xref></sup></p>
<p>In this study, we introduce an easy and simplified way to integrate multiple omics data to show that the survival prediction due to the presence of lncRNAs increases significantly in breast cancer. We consider the genomic platform such as CNV, mRNA expression, proteomic platform such as protein expression, and the phenotype such as the survival of the patients. This study focuses only on the lncRNA expressions from The Cancer Genome Atlas (TCGA) breast cancer data. We consider the target protein expressions as proteomics data.</p>
</sec>
<sec id="section2-1176935119871933">
<title>An Integrative Model</title>
<p>We consider a 3-stage model here. Suppose that <italic>n</italic> is the number of patients, <italic>p</italic> is the number of lncRNAs, and <italic>L</italic> is the number of CNV expressions.</p>
<p>The mechanistic model for each lncRNA can be expressed as</p>
<p>
<disp-formula id="disp-formula1-1176935119871933"><label>(1)</label><alternatives><mml:math id="math1-1176935119871933"><mml:mrow><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi mathvariant="bold-italic">R</mml:mi><mml:mi mathvariant="bold-italic">N</mml:mi><mml:msub><mml:mi mathvariant="bold-italic">A</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>L</mml:mi></mml:munderover><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mspace width="0.25em"></mml:mspace><mml:msub><mml:mi>α</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>Ο</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math><graphic orientation="portrait" position="float" xlink:href="10.1177_1176935119871933-eq1.jpg"></graphic></alternatives></disp-formula>
</p>
<p>where <inline-formula id="inline-formula1-1176935119871933"><mml:math id="math2-1176935119871933"><mml:mrow><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi mathvariant="bold-italic">R</mml:mi><mml:mi mathvariant="bold-italic">N</mml:mi><mml:msub><mml:mi mathvariant="bold-italic">A</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the level of gene expression for gene <inline-formula id="inline-formula2-1176935119871933"><mml:math id="math3-1176935119871933"><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>, and is of dimension <inline-formula id="inline-formula3-1176935119871933"><mml:math id="math4-1176935119871933"><mml:mrow><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>; <inline-formula id="inline-formula4-1176935119871933"><mml:math id="math5-1176935119871933"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is part of the <inline-formula id="inline-formula5-1176935119871933"><mml:math id="math6-1176935119871933"><mml:mrow><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>R</mml:mi><mml:mi>N</mml:mi><mml:msub><mml:mi>A</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> expression that is attributed to the <italic>l</italic>th CNV; <inline-formula id="inline-formula6-1176935119871933"><mml:math id="math7-1176935119871933"><mml:mrow><mml:msub><mml:mi>O</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> is the other (remaining) part of the gene expression which is not regulated by CNV and is of dimension <inline-formula id="inline-formula7-1176935119871933"><mml:math id="math8-1176935119871933"><mml:mrow><mml:mi>n</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>; and <inline-formula id="inline-formula8-1176935119871933"><mml:math id="math9-1176935119871933"><mml:mrow><mml:mi mathvariant="normal">α</mml:mi></mml:mrow></mml:math></inline-formula> is the regression coefficient vector.</p>
<p>Next, the downstream target protein of each specific lncRNA was identified from PubMed articles, TCGA RNA-Seq database, and other extensive analyses such as differential expression analysis. The mechanistic model for each protein (for every lncRNA) can be expressed as</p>
<p>
<disp-formula id="disp-formula2-1176935119871933"><label>(2)</label><alternatives><mml:math id="math10-1176935119871933"><mml:mrow><mml:mi>P</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mi>γ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>O</mml:mi><mml:msub><mml:mi>γ</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msup><mml:mi>O</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:mrow></mml:math><graphic orientation="portrait" position="float" xlink:href="10.1177_1176935119871933-eq2.jpg"></graphic></alternatives></disp-formula>
</p>
<p>where <inline-formula id="inline-formula9-1176935119871933"><mml:math id="math11-1176935119871933"><mml:mrow><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula10-1176935119871933"><mml:math id="math12-1176935119871933"><mml:mrow><mml:msup><mml:mi>O</mml:mi><mml:mo>*</mml:mo></mml:msup></mml:mrow></mml:math></inline-formula> represents the “other” part of the protein expression that is not regulated by lncRNA. <inline-formula id="inline-formula11-1176935119871933"><mml:math id="math13-1176935119871933"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula12-1176935119871933"><mml:math id="math14-1176935119871933"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> are the regression coefficients corresponding to the CNV expressions and the error part from <xref ref-type="disp-formula" rid="disp-formula1-1176935119871933">equation (1)</xref>, respectively.</p>
<p>The clinical component part models the effect of the mechanistic parts of the genes on a clinical outcome of interest and can be written as</p>
<p>
<disp-formula id="disp-formula3-1176935119871933"><label>(3)</label><alternatives><mml:math id="math15-1176935119871933"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi mathvariant="bold-italic">R</mml:mi><mml:mi mathvariant="bold-italic">N</mml:mi><mml:msub><mml:mi mathvariant="bold-italic">A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mspace width="0.25em"></mml:mspace><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi mathvariant="bold-italic">O</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mspace width="0.25em"></mml:mspace><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:mi>ϵ</mml:mi></mml:mrow></mml:math><graphic orientation="portrait" position="float" xlink:href="10.1177_1176935119871933-eq3.jpg"></graphic></alternatives></disp-formula>
</p>
<p>where <inline-formula id="inline-formula13-1176935119871933"><mml:math id="math16-1176935119871933"><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:math></inline-formula> is the survival outcome, <inline-formula id="inline-formula14-1176935119871933"><mml:math id="math17-1176935119871933"><mml:mrow><mml:mi>ϵ</mml:mi></mml:mrow></mml:math></inline-formula> is the error term, and <inline-formula id="inline-formula15-1176935119871933"><mml:math id="math18-1176935119871933"><mml:mrow><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula16-1176935119871933"><mml:math id="math19-1176935119871933"><mml:mrow><mml:msub><mml:mi mathvariant="normal">β</mml:mi><mml:mi>2</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> are the usual regression coefficients corresponding to lncRNA and the estimated error part from <xref ref-type="disp-formula" rid="disp-formula2-1176935119871933">equation (2)</xref>, respectively.</p>
<p>The variable <inline-formula id="inline-formula17-1176935119871933"><mml:math id="math20-1176935119871933"><mml:mrow><mml:mi mathvariant="bold-italic">P</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mi mathvariant="bold-italic">o</mml:mi><mml:mi mathvariant="bold-italic">t</mml:mi><mml:mi mathvariant="bold-italic">e</mml:mi><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mi mathvariant="bold-italic">n</mml:mi></mml:mrow></mml:math></inline-formula> represents the vectorized downstream gene effects attributed to protein expressions and is estimated from the second-stage mechanistic model. Therefore, the clinical component additively models the effects of all the gene expressions and their components—derived from different sources (gene expression, CNV) in a unified manner.</p>
<p>Assumptions such as <inline-formula id="inline-formula18-1176935119871933"><mml:math id="math21-1176935119871933"><mml:mrow><mml:mi mathvariant="normal">O</mml:mi><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>I</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> and <inline-formula id="inline-formula19-1176935119871933"><mml:math id="math22-1176935119871933"><mml:mrow><mml:msup><mml:mi mathvariant="normal">O</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>I</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> give rise to the usual linear model, whereas we obtain the log-normal accelerated failure time (AFT) model when we assume <inline-formula id="inline-formula20-1176935119871933"><mml:math id="math23-1176935119871933"><mml:mrow><mml:mi>ϵ</mml:mi><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>I</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p>
<p>In the presence of right censoring, we observe the tuple <inline-formula id="inline-formula21-1176935119871933"><mml:math id="math24-1176935119871933"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mspace width="0.25em"></mml:mspace><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>, where <inline-formula id="inline-formula22-1176935119871933"><mml:math id="math25-1176935119871933"><mml:mrow><mml:msub><mml:mi mathvariant="normal">δ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> if the event is observed (death in this case), and 0 otherwise; <inline-formula id="inline-formula23-1176935119871933"><mml:math id="math26-1176935119871933"><mml:mrow><mml:msubsup><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">min</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> with <inline-formula id="inline-formula24-1176935119871933"><mml:math id="math27-1176935119871933"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> being the censoring time. A standard statistical software can be used to fit a log-normal AFT model and the other linear regression models.</p>
<p>To quantify the prediction accuracy, we consider a standard comparative predictive approach Brier score (BS)<sup><xref ref-type="bibr" rid="bibr13-1176935119871933">13</xref></sup> which uses the predicted survival times</p>
<p>
<disp-formula id="disp-formula4-1176935119871933"><alternatives><mml:math id="math28-1176935119871933"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mi mathvariant="normal">BS</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msup><mml:mi>n</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mrow><mml:mfrac><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo>|</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>∧</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>K</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>|</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mi>I</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&gt;</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>K</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic orientation="portrait" position="float" xlink:href="10.1177_1176935119871933-eq4.jpg"></graphic></alternatives></disp-formula>
</p>
<p>where <inline-formula id="inline-formula25-1176935119871933"><mml:math id="math29-1176935119871933"><mml:mrow><mml:mover accent="true"><mml:mi>K</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mo>.</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> denotes the Kaplan-Meier estimate of the censoring distribution which is based on the observations <inline-formula id="inline-formula26-1176935119871933"><mml:math id="math30-1176935119871933"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, and <inline-formula id="inline-formula27-1176935119871933"><mml:math id="math31-1176935119871933"><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo stretchy="false">(</mml:mo><mml:mo>.</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> stands for the estimated survival function. As the mathematical form suggests, BS provides a numerical comparison between the observed and estimated survival functions. Brier score is defined for each time point <inline-formula id="inline-formula28-1176935119871933"><mml:math id="math32-1176935119871933"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:math></inline-formula> and hence can be added for the entire time range to obtain IBS, <inline-formula id="inline-formula29-1176935119871933"><mml:math id="math33-1176935119871933"><mml:mrow><mml:mi mathvariant="normal">IBS</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">max</mml:mi><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mn>0</mml:mn><mml:mrow><mml:mi mathvariant="normal">max</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mi mathvariant="normal">BS</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:math></inline-formula>. We can see that models with smaller scores are preferred. We compute integrated Brier score (IBS) using <italic>ipred</italic> package.<sup><xref ref-type="bibr" rid="bibr14-1176935119871933">14</xref></sup></p>
<p>Nevertheless, we also compute the prediction square error by comparing the observed data and their posterior predicted values.</p>
<p>From TCGA database, we consider the information of 222 breast tumor samples with their survival data. We observe that at least 82% data are right censored.</p>
<p>Along with the clinical observations, we also collected measurements of 12 lncRNA expressions (<xref ref-type="table" rid="table1-1176935119871933">Table 1</xref>). Among those, we found the CNV information available for 9 genes (or lncRNAs). We also consider 64 target protein expressions for these genes.</p>
<table-wrap id="table1-1176935119871933" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>The lncRNA considered for our experiment.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1176935119871933-table1"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Gene</th>
<th align="left" colspan="1" rowspan="1">Function</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">
<italic>BCAR4</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes invasion and metastasis<sup><xref ref-type="bibr" rid="bibr15-1176935119871933">15</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>BCYRN1</italic>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes tumor progression<sup><xref ref-type="bibr" rid="bibr16-1176935119871933">16</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>GAS5</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Tumor suppressor<sup><xref ref-type="bibr" rid="bibr17-1176935119871933">17</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>H19</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes proliferation and metastasis<sup><xref ref-type="bibr" rid="bibr18-1176935119871933">18</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>HOTAIR</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes EMT, proliferation, and metastasis<sup><xref ref-type="bibr" rid="bibr19-1176935119871933">19</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>MALAT1</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes proliferation, invasion, and migration<sup><xref ref-type="bibr" rid="bibr20-1176935119871933">20</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>MEG3</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Tumor suppressor, induces accumulation of p53<sup><xref ref-type="bibr" rid="bibr21-1176935119871933">21</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>PVT1</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes tumor progression<sup><xref ref-type="bibr" rid="bibr22-1176935119871933">22</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>SOX2OT</italic>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes tumor growth and metastasis<sup><xref ref-type="bibr" rid="bibr23-1176935119871933">23</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>SRA1</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic<sup><xref ref-type="bibr" rid="bibr24-1176935119871933">24</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>UCA1</italic>
<sup><xref ref-type="table-fn" rid="table-fn2-1176935119871933">a</xref></sup>
</td>
<td colspan="1" rowspan="1">Oncogenic, promotes cell growth, suppresses the tumor suppressor p27<sup><xref ref-type="bibr" rid="bibr25-1176935119871933">25</xref></sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<italic>XIST</italic>
</td>
<td colspan="1" rowspan="1">Tumor suppressor<sup><xref ref-type="bibr" rid="bibr26-1176935119871933">26</xref></sup></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn1-1176935119871933">
<p>Abbreviation: EMT, epithelial-mesenchymal transition.</p>
</fn>
<fn id="table-fn2-1176935119871933">
<label>a</label>
<p>The copy number variation available (among those lncRNAs, <italic>SRA1</italic> transcribes both long noncoding and protein-coding RNAs which are produced by alternative splicing).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>We apply the integrative modeling in these data and obtain the results shown in <xref ref-type="table" rid="table2-1176935119871933">Table 2</xref>. We notice that the mean squared prediction error and IBS are both lower for the proposed model than for the 2-stage model after omitting the protein expressions from the analysis.</p>
<table-wrap id="table2-1176935119871933" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>MSPE and IBS for fitted models in TCGA breast cancer data.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1176935119871933-table2"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Models</th>
<th align="left" colspan="1" rowspan="1">MSPE</th>
<th align="left" colspan="1" rowspan="1">IBS</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">2-stage</td>
<td colspan="1" rowspan="1">1.903</td>
<td colspan="1" rowspan="1">0.488</td>
</tr>
<tr>
<td colspan="1" rowspan="1">3-stage</td>
<td colspan="1" rowspan="1">1.196</td>
<td colspan="1" rowspan="1">0.395</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="table-fn3-1176935119871933">
<p>Abbreviations: IBS, integrated Brier score; MSPE, mean squared prediction error; TCGA, The Cancer Genome Atlas.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In this article, we have shown that when the contribution of lncRNA’s target protein expression measurement is not ignored, then the survival prediction has improved dramatically. Toward this, we have developed a simple yet integrative modeling strategy which borrows strengths from all 3 platforms such as DNA CNV, mRNA expressions for the long noncoding genes, and their target protein expressions to predict the survival of the subjects. We have shown that this integrated model outperforms its closest competitor.</p>
</sec>
</body>
<back>
<ack>
<p>The authors thank the editor and the reviewers for their helpful suggestions which substantially improved this paper.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding:</bold>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: T.R.S. was supported through the NIH T32 Training grant (PI: Dr Raymond J Carroll); A.K.M. and B.K.M. were supported through NIH R01CA194391 (PI: Dr B.K.M.).</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Declaration of conflicting interests:</bold>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="con">
<p><bold>Author Contributions:</bold> TRS, AKM, and BKM designed the study. AKM and YN collected and analyzed the data. TRS and AKM wrote the manuscript.</p>
</fn>
<fn fn-type="other">
<p><bold>ORCID iD:</bold> Tapasree Roy Sarkar <inline-graphic xlink:href="10.1177_1176935119871933-img1.jpg"></inline-graphic>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-8022-6760">https://orcid.org/0000-0001-8022-6760</ext-link></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1176935119871933">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prensner</surname><given-names>JR</given-names></name><name><surname>Chinnaiyan</surname><given-names>AM.</given-names></name></person-group>
<article-title>The emergence of lncRNAs in cancer biology</article-title>. <source/>Cancer Discov. <year>2011</year>;<volume>1</volume>:<fpage>391</fpage>-<lpage>407</lpage>.<pub-id pub-id-type="pmid">22096659</pub-id></mixed-citation>
</ref>
<ref id="bibr2-1176935119871933">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ghoshal</surname><given-names>T</given-names></name></person-group><etal>et al</etal>
<article-title>lncRNA gene signatures for prediction of breast cancer intrinsic subtypes and prognosis</article-title>. <source/>Genes. <year>2018</year>;<volume>9</volume>:<fpage>65</fpage>.</mixed-citation>
</ref>
<ref id="bibr3-1176935119871933">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name></person-group><etal>et al</etal>
<article-title>An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network</article-title>. <source/>Breast Cancer Res Treat. <year>2019</year>;<volume>175</volume>:<fpage>59</fpage>-<lpage>75</lpage>.<pub-id pub-id-type="pmid">30715658</pub-id></mixed-citation>
</ref>
<ref id="bibr4-1176935119871933">
<label>4</label>
<mixed-citation publication-type="journal">
<collab>The Cancer Genome Atlas Network</collab>. <article-title>Comprehensive molecular portraits of human breast tumours</article-title>. <source/>Nature. <year>2012</year>;<volume>490</volume>:<fpage>61</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="pmid">23000897</pub-id></mixed-citation>
</ref>
<ref id="bibr5-1176935119871933">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fan</surname><given-names>B</given-names></name><name><surname>Dachrut</surname><given-names>S</given-names></name><name><surname>Coral</surname><given-names>H</given-names></name></person-group><etal>et al</etal>
<article-title>Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer</article-title>. <source/>PLoS One. <year>2012</year>;<volume>7</volume>:<fpage>e29824</fpage>.<pub-id pub-id-type="pmid">22539939</pub-id></mixed-citation>
</ref>
<ref id="bibr6-1176935119871933">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bass</surname><given-names>AJ</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Mermel</surname><given-names>CH</given-names></name></person-group><etal>et al</etal>
<article-title>SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas</article-title>. <source/>Nat Genet. <year>2009</year>;<volume>41</volume>:<fpage>1238</fpage>-<lpage>1242</lpage>.<pub-id pub-id-type="pmid">19801978</pub-id></mixed-citation>
</ref>
<ref id="bibr7-1176935119871933">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nanjundan</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>KW</given-names></name></person-group><etal>et al</etal>
<article-title>Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer</article-title>. <source/>Cancer Res. <year>2007</year>;<volume>67</volume>:<fpage>3074</fpage>-<lpage>3084</lpage>.<pub-id pub-id-type="pmid">17409414</pub-id></mixed-citation>
</ref>
<ref id="bibr8-1176935119871933">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scott</surname><given-names>KL</given-names></name><name><surname>Kabbarah</surname><given-names>O</given-names></name><name><surname>Liang</surname><given-names>MC</given-names></name></person-group><etal>et al</etal>
<article-title>GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer</article-title>. <source/>Nature. <year>2009</year>;<volume>459</volume>:<fpage>1085</fpage>-<lpage>1090</lpage>.<pub-id pub-id-type="pmid">19553991</pub-id></mixed-citation>
</ref>
<ref id="bibr9-1176935119871933">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Baladandayuthapani</surname><given-names>V</given-names></name><name><surname>Morris</surname><given-names>JS</given-names></name></person-group><etal>et al</etal>
<article-title>iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data</article-title>. <source/>Bioinformatics. <year>2012</year>;<volume>29</volume>:<fpage>149</fpage>-<lpage>159</lpage>.<pub-id pub-id-type="pmid">23142963</pub-id></mixed-citation>
</ref>
<ref id="bibr10-1176935119871933">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>SH</given-names></name><name><surname>Huang</surname><given-names>YT.</given-names></name></person-group>
<article-title>Integrated genomic analysis of biological gene sets with applications in lung cancer prognosis</article-title>. <source/>BMC Bioinformatics. <year>2017</year>;<volume>18</volume>:<fpage>336</fpage>.<pub-id pub-id-type="pmid">28697753</pub-id></mixed-citation>
</ref>
<ref id="bibr11-1176935119871933">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>MC</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Epstein</surname><given-names>MP</given-names></name></person-group><etal>et al</etal>
<article-title>Powerful SNP-set analysis for case-control genome-wide association studies</article-title>. <source/>Am J Hum Genet. <year>2010</year>;<volume>86</volume>:<fpage>929</fpage>-<lpage>942</lpage>.<pub-id pub-id-type="pmid">20560208</pub-id></mixed-citation>
</ref>
<ref id="bibr12-1176935119871933">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name></person-group><etal>et al</etal>
<article-title>DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics</article-title>. <source/>Mol Autism. <year>2014</year>;<volume>5</volume>:<fpage>22</fpage>.<pub-id pub-id-type="pmid">24602502</pub-id></mixed-citation>
</ref>
<ref id="bibr13-1176935119871933">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Graf</surname><given-names>E</given-names></name><name><surname>Schmoor</surname><given-names>C</given-names></name><name><surname>Sauerbrei</surname><given-names>W</given-names></name><name><surname>Schumacher</surname><given-names>M.</given-names></name></person-group>
<article-title>Assessment and comparison of prognostic classification schemes for survival data</article-title>. <source/>Stat Med. <year>1999</year>;<volume>18</volume>: <fpage>2529</fpage>-<lpage>2545</lpage>.<pub-id pub-id-type="pmid">10474158</pub-id></mixed-citation>
</ref>
<ref id="bibr14-1176935119871933">
<label>14</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Hothorn</surname><given-names>T.</given-names></name></person-group>
<article-title>Ipred: improved predictors (R package version 0.9-6)</article-title>. <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=ipred">https://CRAN.R-project.org/package=ipred</ext-link>. Updated 2017.</mixed-citation>
</ref>
<ref id="bibr15-1176935119871933">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xing</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>PK</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name></person-group>
<article-title>LncRNA BCAR4 wires up signaling transduction in breast cancer</article-title>. <source/>RNA Biol. <year>2015</year>;<volume>12</volume>:<fpage>681</fpage>-<lpage>689</lpage>.<pub-id pub-id-type="pmid">26016563</pub-id></mixed-citation>
</ref>
<ref id="bibr16-1176935119871933">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><etal>et al</etal>
<article-title>Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma</article-title>. <source/>Oncotarget. <year>2018</year>;<volume>9</volume>:<fpage>4851</fpage>-<lpage>4861</lpage>.<pub-id pub-id-type="pmid">29435146</pub-id></mixed-citation>
</ref>
<ref id="bibr17-1176935119871933">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group>
<article-title>Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p</article-title>. <source/>Biomed Pharmacother. <year>2018</year>;<volume>104</volume>:<fpage>451</fpage>-<lpage>457</lpage>.<pub-id pub-id-type="pmid">29793177</pub-id></mixed-citation>
</ref>
<ref id="bibr18-1176935119871933">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barsyte-Lovejoy</surname><given-names>D</given-names></name><name><surname>Lau</surname><given-names>SK</given-names></name><name><surname>Boutros</surname><given-names>PC</given-names></name></person-group><etal>et al</etal>
<article-title>The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis</article-title>. <source/>Cancer Res. <year>2006</year>;<volume>66</volume>:<fpage>5330</fpage>-<lpage>5337</lpage>.<pub-id pub-id-type="pmid">16707459</pub-id></mixed-citation>
</ref>
<ref id="bibr19-1176935119871933">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><etal>et al</etal>
<article-title>MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway</article-title>. <source/>Stem Cells. <year>2014</year>;<volume>32</volume>:<fpage>2858</fpage>-<lpage>2868</lpage>.<pub-id pub-id-type="pmid">25070049</pub-id></mixed-citation>
</ref>
<ref id="bibr20-1176935119871933">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Sui</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><etal>et al</etal>
<article-title>Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer</article-title>. <source/>Int J Clin Exp Pathol. <year>2015</year>;<volume>8</volume>:<fpage>4881</fpage>-<lpage>4891</lpage>.<pub-id pub-id-type="pmid">26191181</pub-id></mixed-citation>
</ref>
<ref id="bibr21-1176935119871933">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name></person-group>
<article-title>Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53’s transcriptional activity</article-title>. <source/>Biochem Biophys Res Commun. <year>2016</year>;<volume>478</volume>:<fpage>323</fpage>-<lpage>329</lpage>.<pub-id pub-id-type="pmid">27166155</pub-id></mixed-citation>
</ref>
<ref id="bibr22-1176935119871933">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name></person-group><etal>et al</etal>
<article-title>LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis</article-title>. <source/>Mol Cancer. <year>2018</year>;<volume>17</volume>:<fpage>77</fpage>.<pub-id pub-id-type="pmid">29618386</pub-id></mixed-citation>
</ref>
<ref id="bibr23-1176935119871933">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>XM</given-names></name><name><surname>Teng</surname><given-names>F.</given-names></name></person-group>
<article-title>Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis</article-title>. <source/>Int J Clin Exp Pathol. <year>2015</year>;<volume>8</volume>:<fpage>4008</fpage>-<lpage>4014</lpage>.<pub-id pub-id-type="pmid">26097588</pub-id></mixed-citation>
</ref>
<ref id="bibr24-1176935119871933">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leygue</surname><given-names>E</given-names></name><name><surname>Dotzlaw</surname><given-names>H</given-names></name><name><surname>Watson</surname><given-names>PH</given-names></name></person-group><etal>et al</etal>
<article-title>Expression of the steroid receptor RNA activator in human breast tumors</article-title>. <source/>Cancer Research. <year>1999</year>;<volume>59</volume>:<fpage>4190</fpage>-<lpage>4193</lpage>.<pub-id pub-id-type="pmid">10485452</pub-id></mixed-citation>
</ref>
<ref id="bibr25-1176935119871933">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>N</given-names></name><name><surname>Watabe</surname><given-names>K</given-names></name></person-group><etal>et al</etal>
<article-title>Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)</article-title>. <source/>Cell Death Dis. <year>2015</year>;<volume>5</volume>:<fpage>e1008</fpage>.</mixed-citation>
</ref>
<ref id="bibr26-1176935119871933">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>YS</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Jou</surname><given-names>YS</given-names></name><name><surname>Shih</surname><given-names>HM.</given-names></name></person-group>
<article-title>Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression</article-title>. <source/>Oncotarget. <year>2016</year>;<volume>7</volume>:<fpage>43256</fpage>-<lpage>43266</lpage>.<pub-id pub-id-type="pmid">27248326</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>